MeSH D005414 - flatulence
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Aurobindo Pharma | Loperamide, Simethicone | Loperamide Simethicone | 2020-12-14 | |||
| BionPharma | Loperamide, Simethicone | Loperamide Simethicone | 2021-09-10 | |||
| Bracco Diagnostics | Simethicone-cellulose | Sonorx | 1998-10-29 | |||
| Granules Pharmaceuticals | Loperamide, Simethicone | Loperamide Simethicone | 2022-08-29 | |||
| Hetero | Loperamide, Simethicone | Loperamide Simethicone | 2021-06-17 | |||
| Innovative Drug Delivery Systems | Loperamide, Simethicone | Loperamide Simethicone | 2021-05-27 | |||
| Johnson & Johnson | Loperamide, Simethicone | Imodium Multi-symptom | 1996-06-26 | |||
| Perrigo | Loperamide, Simethicone | Loperamide Simethicone | 2002-08-30 | |||
| Sun Pharmaceutical Industries | Loperamide, Simethicone | Loperamide Simethicone | 2006-09-06 | |||
| Takeda | Agalsidase alfa | Replagal | 2001-08-03 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use